Matthew S. Wiebe

1.2k citations
26 papers · 911 indexed · h-index 16

Matthew S. Wiebe

26 papers receiving 906 citations

Peers

Matthew S. Wiebe
Comparison fields: 5 of 73
  • Virology 162
  • Molecular Biology 631
  • Genetics 244
  • Cell Biology 96
  • Immunology 124
Replace Kevin S. Dingwell with:
Kevin S. Dingwell United Kingdom
Olaf Rosorius Germany
Agnès Méreau France
Judy K. VanSlyke United States
Carolyn L. Dent United Kingdom
Laura Doglio United Kingdom
Annarita Miccio France
Akinori Ishimoto Japan
Roger B. Slee United States
Colin Macaulay United States
Matthew S. Wiebe relative to Kevin S. Dingwell United Kingdom Kevin S. Dingwell's profile →
Citations per field
00.5×1.5×2.1×
Kevin S. Dingwell · 1×
Citations per year

Countries citing papers authored by Matthew S. Wiebe

Since Specialization
Citations

This map shows the geographic impact of Matthew S. Wiebe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew S. Wiebe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew S. Wiebe more than expected).

Fields of papers citing papers by Matthew S. Wiebe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew S. Wiebe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew S. Wiebe. The network helps show where Matthew S. Wiebe may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Matthew S. Wiebe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Matthew S. Wiebe Line = papers co-authored together Matthew S. Wiebe links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20226
2 20204
3 201920
4 20192
5 20194
6 201625
7 201574
8 201419
9 201415
10 201325
11 201219
12 201142
13 200941
14 200788
15 200513
16 200360
17 200057
18 200077
19
Endogenous retroviruses of continuous cell substrates.
19897
20 198738

About Matthew S. Wiebe

Matthew S. Wiebe is a scholar working on Virology, Genetics and Developmental Biology, having authored 26 papers that have together received 911 indexed citations. Recurring topics across this work include Virus-based gene therapy research (15 papers), Poxvirus research and outbreaks (13 papers), Herpesvirus Infections and Treatments (7 papers), interferon and immune responses (5 papers), Plant Virus Research Studies (5 papers), Nuclear Structure and Function (3 papers), Genomics and Chromatin Dynamics (3 papers) and Bacteriophages and microbial interactions (2 papers). The work is most often cited by research in Virology (162 citations), Molecular Biology (631 citations) and Genetics (244 citations). Matthew S. Wiebe has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Paula Traktman, R. Jeremy Nichols, Angie Rizzino, Tamara K. Nowling, David L. Kelly, Timothy A. Springer, L J Miller, Clinton Jones, Zhigang Wang and Jesse L. Cox. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026